U.S. Markets closed

Freeline Therapeutics Holdings plc (FRLN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.8500+0.1200 (+3.22%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.7300
Open3.8000
Bid3.6600 x 1100
Ask4.0800 x 1300
Day's Range3.6900 - 3.9500
52 Week Range2.9200 - 18.8800
Volume78,286
Avg. Volume468,800
Market Cap138.016M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.25
  • GlobeNewswire

    Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease

    Clinical trial site initiation for Gaucher disease Type 1 on track by year endLONDON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that both the U.S. Food and Drug Administration (“FDA”) and European Commission (“EC”) have granted Orphan Drug Designa

  • GlobeNewswire

    Freeline to Participate in Upcoming Investor Conferences in September 2021

    LONDON, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that Chief Executive Officer Michael Parini is scheduled to present at the following virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, Fi

  • Simply Wall St.

    Is Freeline Therapeutics Holdings (NASDAQ:FRLN) In A Good Position To Deliver On Growth Plans?

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...